Zhengrong Real Estate and others were forced to execute 230 million yuan. According to the information of legal proceedings, recently, Zhengrong Real Estate Holdings Co., Ltd. and Minhou Zhenghong Real Estate Development Co., Ltd. added a piece of information about the person to be executed, with an execution target of more than 230 million yuan. The enforcement court is Fuzhou Intermediate People's Court of Fujian Province.Market news: Israel said that the IDF will stay on the Syrian side of Mount Hermon for several months.Exclusive Baidu Geely Joint Voice: The transfer process has been completed, and the social security for employees of Jiyue was paid in November. On the afternoon of December 13th, Sina Technology learned exclusively that Baidu and Geely Automobile, the two major shareholders of Jiyue Automobile, have reached a consensus today and jointly stated that as shareholders, they will actively assist the management of Jiyue to properly handle related matters: the social security payment for employees and the compensation for employees who leave their posts will be solved as soon as possible; Maintain the normal use, after-sales and maintenance of users' vehicles; Promote the reasonable and legal settlement of other matters. According to reports, Geely and Baidu have completed the transfer process on the evening of the 12th, and paid social security for the employees in November. It is reported that Jidu Automobile Co., Ltd. is a new start-up company established by Geely Holding and Baidu Holding, and it is an innovative product to explore the intelligent transformation of automobiles. Jiyue automobile products are manufactured by Geely factory and authorized to operate exclusively by Jidu. Due to the great changes in the industry competition pattern, the established business plan cannot be implemented and the operation has encountered challenges. (Sina Technology)
Huifa Food: Shareholder Zhenghechang Investment Co., Ltd.' s shareholding reduction plan has not been completed yet, and Huifa Food announced the change. On November 8, 2024, the company disclosed the Announcement of Huifa Food Shareholder's shareholding reduction plan, and Shareholder Zhenghechang Investment Co., Ltd. plans to reduce its shareholding by centralized bidding to no more than 2,446,423 shares, which does not exceed 1% of the company's total share capital; The reduction of holdings through block trading does not exceed 4,892,846 shares, and does not exceed 2% of the company's total share capital. The planned reduction period is from November 29, 2024 to February 27, 2025. As of December 13, 2024, shareholder Zhenghechang Investment Co., Ltd. has reduced its shareholding by 1.7 million shares through centralized bidding. At present, the shareholder's shareholding reduction plan has not been completed.SINOMACH Seiko: It is planned to invest 73.6 million yuan to build an industrialization project of superhard tool. The company plans to invest in the industrialization project of superhard tool, and the main body of implementation is SINOMACH Diamond (Henan) Co., Ltd., a holding subsidiary of the company holding 67% equity. The total investment of the project is 73.6 million yuan, and the project construction period is about 12 months.The screening of the 6th Hainan Island International Film Festival-Spanish Film Week was successfully held. From December 4th to 14th, the screening of the 6th Hainan Island International Film Festival-Spanish Film Week, co-sponsored by the Central Radio and Television General Station and the Hainan Provincial People's Government, came to a successful conclusion. Eighteen excellent Spanish films with rich themes and different styles, such as The Ghost of Beehive, The Confusion of Pink Flamingo and Parting Party, were held in Haikou and Haikou. (CCTV News)
Zhang Liling, Assistant Managing Director (Economic Research) of the Hong Kong Monetary Authority, will leave in May next year. On December 13th, the Hong Kong Monetary Authority announced that Ms. Zhang Liling, Assistant Managing Director (Economic Research), has resigned for personal reasons and will leave in May 2025. The Hong Kong Monetary Authority will arrange an open recruitment for the post of Assistant President (Economic Research), and will make a separate announcement after the recruitment process is completed.Yili shares: invested 130 million yuan to set up Anhui Jianwei Seed Fund. Yili shares announced that the company's wholly-owned limited partnerships, Jianwei Capital, Jianwei Seed Fund, Jianwei Parent Fund and Anhui Seed Fund jointly invested to set up Anhui Jianwei Seed Fund, with a total subscribed capital of 200 million yuan, and the company's wholly-owned limited partnerships contributed a total of 130 million yuan. The partnership term of the partnership enterprise is 12 years, and the fund can be extended twice for 1 year at the expiration of the term. The investment direction is mainly for the top ten emerging industries in Anhui Province, the future industries in the layout of new industries in various cities in the province and other key industries developed by the municipal government, focusing on small and medium-sized scientific and technological innovative enterprises with certain scientific and technological content and relatively new business models.Borui Medicine: Carboprost injection is planned to win the bid for the national centralized drug procurement. Borui Medicine announced that in the tenth batch of national centralized drug procurement in which Borui Pharmaceutical, a wholly-owned subsidiary, participated, carboprost tromethamine injection is planned to win the bid. This product is mainly used for 13-20 weeks pregnant abortion and postpartum hemorrhage. The specification is 1 ml: 250μ g, and the proposed bid price is 16.96 yuan/piece. In the first year, the agreed purchase base is 220,400 pieces, which are mainly supplied to Henan, Hubei, Guangxi, Shaanxi, Gansu, Ningxia and other provinces. If the contract is finally selected and signed, it will help the product to quickly open the domestic market and enhance the market share and brand influence of the company. The product obtained the drug registration certificate in March 2024, and has not yet generated sales revenue.
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
Strategy guide
12-14